PlainRecalls
FDA Devices Moderate Class II Ongoing

CardiFocus Heartlight X3 Catheter- Intended in the treatment of atrial fibrillation. It is introduced percutaneously in the setting of an Electrophysiology or Catheterization Laboratory Model: 18-5000

Reported: March 19, 2025 Initiated: February 7, 2025 #Z-1307-2025

Product Description

CardiFocus Heartlight X3 Catheter- Intended in the treatment of atrial fibrillation. It is introduced percutaneously in the setting of an Electrophysiology or Catheterization Laboratory Model: 18-5000

Reason for Recall

Damage to the sterile barrier pouch of catheter, which could potentially compromise its sterility.

Details

Recalling Firm
CardioFocus, Inc.
Units Affected
833 units
Distribution
Worldwide distribution - US Nationwide and the countries of Belgium, Czech Republic, Italy, Japan, United Kingdom.
Location
Marlborough, MA

Frequently Asked Questions

What product was recalled?
CardiFocus Heartlight X3 Catheter- Intended in the treatment of atrial fibrillation. It is introduced percutaneously in the setting of an Electrophysiology or Catheterization Laboratory Model: 18-5000. Recalled by CardioFocus, Inc.. Units affected: 833 units.
Why was this product recalled?
Damage to the sterile barrier pouch of catheter, which could potentially compromise its sterility.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 19, 2025. Severity: Moderate. Recall number: Z-1307-2025.